#DrugDiscovery #Antifungal #PrecisionMedicine #SafetyFirst #Fluconazole To view or add a comment, sign in GLP-1s: Powerful but not simple GLP-1 receptor agonists are reshaping metabolic disease treatment, but their impact extends far beyond weight loss
For patients with PCOS, long-term treatment offers additional benefits
The consequences can be Increased side effects such as nausea, bloating or circulatory problems because the stomach is emptied even more slowly
It is one of the two active ingredients in Qsymia but is also prescribed as a standalone medication
When food enters the digestive system, GLP-1 is released into the bloodstream, where it exerts multiple beneficial effects on metabolic health, though it has a very short half-life due to rapid degradation by the enzyme dipeptidyl peptidase-4 (DPP-4)
Many patients benefit from marking their injection sites with a pen beforehand so they know exactly where to aim and can avoid injecting too close to old sites